Susceptibility testing ofCryptococcus diffluensagainst amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole [PDF]
A. Serda Kantarcıoğlu+3 more
openalex +1 more source
A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database. [PDF]
Tian Y, Jin M, Ning H.
europepmc +1 more source
Assessment of the Effective Dose of Isavuconazole, Itraconazole, Posaconazole, and Voriconazole to Achieve Goal Serum Concentrations in Pediatric Patients at a Single Center. [PDF]
Kennedy KL+5 more
europepmc +1 more source
Establishment of epidemiological cutoff values for <i>Fonsecaea pedrosoi</i>, the primary etiologic agent of chromoblastomycosis, and eight antifungal medications. [PDF]
Smith DJ+15 more
europepmc +1 more source
Rhino-orbito-cerebral mucormycosis after allogeneic hematopoietic stem cell transplantation for very severe aplastic anemia in a child: a case report. [PDF]
Ma Y+5 more
europepmc +1 more source
Appraisal of guidelines and variations in recommendations on drug therapy for invasive aspergillosis prevention and treatment. [PDF]
Wang J+5 more
europepmc +1 more source
Phaeoacremonium iranianum - a new corneal pathogen. [PDF]
Liu X, Lu X, Zheng J, Liu S, Li M.
europepmc +1 more source